SeptumSegment

SeptumSegment represents an innovative solution in rhinoplasty, offering precisely sized costal cartilage for both primary and complex surgical procedures. For decades, cartilage has been recognized as a safe and effective substitute for autologous grafts or synthetic materials, boasting high biocompatibility. SeptumSegment stands out for its consistent quality, with studies indicating low complication rates [1], ensuring reliable functional, structural, and cosmetic outcomes with minimal adverse effects [2].

This product underscores its value in cases where patients lack sufficient or high-quality cartilage, serving as an optimal alternative. Clinical evidence highlights the advantages of SeptumSegment over autologous grafts, notably avoiding the additional risks associated with secondary donor sites, such as extended anesthesia and increased infection potential.

Designed for immediate application, SeptumSegment can be tailored to any required dimensions, facilitating a safe and efficient rhinoplasty process. Available in two length variations—over 15 mm and over 30 mm—and in both freeze-dried and fresh-frozen formats, SeptumSegment is a versatile and dependable choice for enhancing patient outcomes in rhinoplasty surgeries.

SeptumSegment represents a fusion of innovation and clinical utility. Medical devices, as outlined by the FD&C Act, are essential tools ranging from diagnostic instruments to implants. Unlike these devices, biologics—categorized as tissues and cellular-based products—are poised for human therapeutic use and can garner additional reimbursement when billed under the unlisted CPT Code 17999.